A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome.

David G SweetMark A TurnerZbyněk StraňákRichard PlavkaPaul ClarkeBen J StensonDominique SingerRangmar GoelzLaura FabbriGuido VaroliAnnalisa PiccinnoDebora SantoroChristian P Speer

Published in: Archives of disease in childhood. Fetal and neonatal edition (2017)

ClinicalTrials.gov NCT01651637.

Keyphrases

endothelial cells
gestational age
induced pluripotent stem cells
low birth weight
preterm birth
pluripotent stem cells
case report
clinical trial
double blind
preterm infants